[1]
H.-D. Bäuerle, “Is Switzerland Still a Lucrative Place for Manufacturers of Drug Substances to Produce Their Products?”, Chimia, vol. 59, no. 1-2, p. 28, Jan. 2005, doi: 10.2533/000942905777676894.